부산대학교 도서관

QuidelOrtho Corp., a diagnostics company based in San Diego, California, is considering selling its transfusion medicine unit, which could be worth $1.5 billion to $2 billion. The company is working with advisors to gauge interest in the unit from potential buyers, including both strategic and private equity investors. QuidelOrtho inherited the transfusion medicine business when it acquired Ortho Clinical Diagnostics Holdings Plc in 2022. The unit sells instruments and tests that help with blood transfusions and screening for diseases. QuidelOrtho's shares have fallen this year after a surge during the Covid-19 pandemic, and the company's market value is currently around $4.2 billion. Mergers and acquisitions in the healthcare sector have remained strong this year, with deals worth approximately $255 billion. Siemens Healthineers AG is also considering selling its diagnostics segment, which could be valued at up to $8 billion. [Extracted from the article]